Diagnostics for Diseases of Abnormal Protein Glycosylation
Tech ID: 20937 / UC Case 1999-001-0
Technology Description
Two UC researchers have discovered a class of new analytes and new methods for using them, both are directed to in vitro diagnostic assays for diseases of abnormal protein glycosylation. This invention provides a technological base for a new line of diagnostic products to address this emerging area—the diagnosis and treatment of glycosylation abnormalities leading to peri- and post-natal disease, the widespread nature of which has recently become recognized.Advantages
- New market potential—a new line of in vitro diagnostic assays based on these analytes is possible.
- Versatile and amendable to various assay methodologies, including radioisotope, enzyme, and fluorescence based methodologies.
- State-of-the art and based on the results of research at frontiers of medicine.
Related Materials
- Hudson H. Freeze.1998. Disorders in Protein Glycosylation and Potential Therapy: Tip of an Iceberg? Journal of Pediatrics.133 (5).
Patent Status
| Country | Type | Number | Dated | Case |
| United States Of America | Issued Patent | 7,674,577 | 03/09/2010 | 1999-001 |
| United States Of America | Issued Patent | 7,273,711 | 09/25/2007 | 1999-001 |
Other Information
Categorized As
Related cases
1999-001-0
Keywords
diagnostic assays, carbohydrate-based disorders, peri-natal, post-natal
Contact
University of California, San Diego Technology Transfer Office / invent@ucsd.edu / tel: View Phone Number. Please reference Tech ID #20937.